The Supreme Court decision that raised the bar for getting and maintaining patents as a result of KSR v. Teleflex, continues to raise questions for drug, biotech, and medical device companies a year later.
In a new Medical Device Daily and BioWorld Today audio conference, speakers Bruce D. Sunstein, co-founder of Bromberg & Sunstein, and Barbara J. Carter, Ph.D., associate at Bromberg & Sunstein, will offer tools and techniques to deal with the effects of the KSR v. Teleflex decision. They will also address interventions most susceptible to failure in the patent prosecution process.
"Building and Maintaining BioPharma Patent Portfolios After KSR v. Teleflex: Strategies Addressing Higher Standards for Patentability" is just $349 per listening site. Scheduled for June 11th, from 1-2:30 p.m., it includes presentation handouts and a half-hour Q&A session with the speaker. A conference CD (MP3 format) is also available. For more information or to register, call 800-688-2421 or 404-262-5474. Please mention conference code T08497.